Literature DB >> 7392755

DNA and its synthesis in individual tumor cells from human upper respiratory tract squamous cell carcinomas.

L E Holm, P Jakobsson, D Killander, C Silfverswärd, J Wersäll.   

Abstract

Measurements of cytophotometric Feulgen DNA content and incorporation of 3H-thymidine were made in individual tumor cells from 58 patients with squamous cell carcinomas of the head-neck region. These measurements were correlated with a point ranking system for pathological grading for these types of tumors. Two of the parameters of the grading system, mode of invasion and nuclear polymorphism which had been found to be important factors in prognosis in clinical studies were correlated to the objective cellular DNA measurements. In 40 carcinomas, 10 were found to have a predominantly diploid distribution of DNA values, while the remaining 30 tumor values were either multiples of diploid or were aneuploid. Generally, tumors with low point rankings for individual morphological parameters tended to have diploid DNA values. Those tumors with higher DNA values usually had larger point rankings and more advanced clinical stage. When tumor cells from biopsies of 39 patients were studied by 3H-thymidine incorporation, no relevant connections between the labeling index and cellular DNA amounts, malignancy grading, or clinical stage were found.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7392755     DOI: 10.1288/00005537-198007000-00017

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  2 in total

1.  Ploidy as a prognostic indicator in end stage squamous cell carcinoma of the head and neck region treated with cisplatinum.

Authors:  L D Cooke; T G Cooke; F Bootz; G Forster; T R Helliwell; D Spiller; P M Stell
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

2.  DNA content, malignancy grading and prognosis in T1 and T2 oral cavity carcinomas.

Authors:  M Tytor; G Franzén; J Olofsson; U Brunk; B Nordenskjöld
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.